If I understand correctly, we don't have new trials, we have new trial "development" which is quite different. CYDY may very well need Big Pharma to actually run those trials effectively, which would mean that BP has the leverage there.

I know we all want to tell Big Pharma they'll have to pay through the nose for CYDY, but I still don't quite see that as being the case just yet. Remember, this management team was built to sell the company, not advance trials.